129 related articles for article (PubMed ID: 29644923)
21. Gauging the effectiveness of extended imipramine treatment for panic disorder with agoraphobia.
Mavissakalian MR; Perel JM; Talbott-Green M; Sloan C
Biol Psychiatry; 1998 Jun; 43(11):848-54. PubMed ID: 9611676
[TBL] [Abstract][Full Text] [Related]
22. Serotonin, panic disorder and agoraphobia: short-term and long-term efficacy of citalopram in panic disorders.
Humble M; Wistedt B
Int Clin Psychopharmacol; 1992 Jun; 6 Suppl 5():21-39. PubMed ID: 1431019
[TBL] [Abstract][Full Text] [Related]
23. The structure of lifetime panic-agoraphobic spectrum.
Rucci P; Miniati M; Oppo A; Mula M; Calugi S; Frank E; Shear MK; Mauri M; Pini S; Cassano GB
J Psychiatr Res; 2009 Jan; 43(4):366-79. PubMed ID: 18499126
[TBL] [Abstract][Full Text] [Related]
24. Are SSRIs and TCAs equally effective for the treatment of panic disorder?
Brokaw DK
J Fam Pract; 2002 Mar; 51(3):279. PubMed ID: 11978241
[No Abstract] [Full Text] [Related]
25. A naturalistic long-term comparison study of selective serotonin reuptake inhibitors in the treatment of panic disorder.
Dannon PN; Iancu I; Lowengrub K; Gonopolsky Y; Musin E; Grunhaus L; Kotler M
Clin Neuropharmacol; 2007; 30(6):326-34. PubMed ID: 18090457
[TBL] [Abstract][Full Text] [Related]
26. Does fear reactivity during exposure predict panic symptom reduction?
Meuret AE; Seidel A; Rosenfield B; Hofmann SG; Rosenfield D
J Consult Clin Psychol; 2012 Oct; 80(5):773-85. PubMed ID: 22486408
[TBL] [Abstract][Full Text] [Related]
27. Effect of dissociative experiences on drug treatment of panic disorder.
Gulsun M; Doruk A; Uzun O; Turkbay T; Ozsahin A
Clin Drug Investig; 2007; 27(8):583-90. PubMed ID: 17638399
[TBL] [Abstract][Full Text] [Related]
28. Follow-up study of patients with panic disorder and agoraphobia with panic attacks treated with tricyclic antidepressants.
Noyes R; Garvey MJ; Cook BL
J Affect Disord; 1989; 16(2-3):249-57. PubMed ID: 2522124
[TBL] [Abstract][Full Text] [Related]
29. Separating depressive comorbidity from panic disorder: A combined functional magnetic resonance imaging and machine learning approach.
Lueken U; Straube B; Yang Y; Hahn T; Beesdo-Baum K; Wittchen HU; Konrad C; Ströhle A; Wittmann A; Gerlach AL; Pfleiderer B; Arolt V; Kircher T
J Affect Disord; 2015 Sep; 184():182-92. PubMed ID: 26093832
[TBL] [Abstract][Full Text] [Related]
30. A prospective naturalistic study of 326 panic-agoraphobic patients treated with antidepressants.
Toni C; Perugi G; Frare F; Mata B; Vitale B; Mengali F; Recchia M; Serra G; Akiskal HS
Pharmacopsychiatry; 2000 Jul; 33(4):121-31. PubMed ID: 10958260
[TBL] [Abstract][Full Text] [Related]
31. MAO inhibitors in panic disorder: clinical effects of treatment with brofaromine. A double blind placebo controlled study.
van Vliet IM; Westenberg HG; Den Boer JA
Psychopharmacology (Berl); 1993; 112(4):483-9. PubMed ID: 7871061
[TBL] [Abstract][Full Text] [Related]
32. Effect of cognitive-behavioral therapy on neural correlates of fear conditioning in panic disorder.
Kircher T; Arolt V; Jansen A; Pyka M; Reinhardt I; Kellermann T; Konrad C; Lueken U; Gloster AT; Gerlach AL; Ströhle A; Wittmann A; Pfleiderer B; Wittchen HU; Straube B
Biol Psychiatry; 2013 Jan; 73(1):93-101. PubMed ID: 22921454
[TBL] [Abstract][Full Text] [Related]
33. Effects of gradual discontinuation of selective serotonin reuptake inhibitors in panic disorder with agoraphobia.
Fava GA; Bernardi M; Tomba E; Rafanelli C
Int J Neuropsychopharmacol; 2007 Dec; 10(6):835-8. PubMed ID: 17224089
[TBL] [Abstract][Full Text] [Related]
34. Early improvement predicts endpoint remission status in sertraline and placebo treatments of panic disorder.
Pollack MH; Rapaport MH; Fayyad R; Otto MW; Nierenberg AA; Clary CM
J Psychiatr Res; 2002; 36(4):229-36. PubMed ID: 12191627
[TBL] [Abstract][Full Text] [Related]
35. Alprazolam treatment for panic disorders.
Alexander PE; Alexander DD
J Clin Psychiatry; 1986 Jun; 47(6):301-4. PubMed ID: 2872205
[TBL] [Abstract][Full Text] [Related]
36. Cognitive factors in panic disorder, agoraphobic avoidance and agoraphobia.
Berle D; Starcevic V; Hannan A; Milicevic D; Lamplugh C; Fenech P
Behav Res Ther; 2008 Feb; 46(2):282-91. PubMed ID: 18191103
[TBL] [Abstract][Full Text] [Related]
37. Clomipramine in the treatment of agoraphobic inpatients resistant to behavioral therapy.
Hoffart A; Due-Madsen J; Lande B; Gude T; Bille H; Torgersen S
J Clin Psychiatry; 1993 Dec; 54(12):481-7. PubMed ID: 8276739
[TBL] [Abstract][Full Text] [Related]
38. What treatments do patients with panic disorder and agoraphobia get?
Bandelow B; Sievert K; Röthemeyer M; Hajak G; Rüther E
Eur Arch Psychiatry Clin Neurosci; 1995; 245(3):165-71. PubMed ID: 7669824
[TBL] [Abstract][Full Text] [Related]
39. Moderators and mediators among panic, agoraphobia symptoms, and suicidal ideation in patients with panic disorder.
Huang MF; Yen CF; Lung FW
Compr Psychiatry; 2010; 51(3):243-9. PubMed ID: 20399333
[TBL] [Abstract][Full Text] [Related]
40. Are benzodiazepines still the medication of choice for patients with panic disorder with or without agoraphobia?
Bruce SE; Vasile RG; Goisman RM; Salzman C; Spencer M; Machan JT; Keller MB
Am J Psychiatry; 2003 Aug; 160(8):1432-8. PubMed ID: 12900305
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
